161 – 170 of 363
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Effects of repeated botulinum toxin a injection therapy in patients with sympthomatic neurogenic detrusor overactivity - a 3-year follow up
2009) 39th Annual Meeting of the International-Continence-Society In Neurourology and Urodynamics 28(7). p.35-35(
- Contribution to journal › Published meeting abstract
-
Mark
UROSTOMY AND QUALITY OF LIFE IN PATIENTS WITH DISABLING LOWER URINARY TRACT DYSFUNCTION: A PROSPECTIVE STUDY
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.302-302(
- Contribution to journal › Published meeting abstract
-
Mark
EXTENDED LYMPH NODE DISSECTION IN PATIENTS WITH UROTHELIAL CELL CARCINOMA OF THE BLADDER: CAN IT MAKE A DIFFERENCE?
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.256-256(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries
(
- Contribution to journal › Article
-
Mark
A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden
(
- Contribution to journal › Article
-
Mark
ORTHOTOPIC BLADDER SUBSTITUTES AT 12 MONTHS: WHICH IS THE BEST?
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.301-301(
- Contribution to journal › Published meeting abstract
-
Mark
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
(
- Contribution to journal › Article
-
Mark
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
(
- Contribution to journal › Article
-
Mark
Should All Patients with Non-Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study.
(
- Contribution to journal › Article